{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:54:18Z","timestamp":1792450458985,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.iac.2016.08.017","type":"journal-article","created":{"date-parts":[[2016,10,28]],"date-time":"2016-10-28T22:18:03Z","timestamp":1477693083000},"page":"153-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":79,"title":["Mastocytosis and Anaphylaxis"],"prefix":"10.1016","volume":"37","author":[{"given":"Anna","family":"Schuch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Brockow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.iac.2016.08.017_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1056\/NEJMra1409760","article-title":"Mast cells, mastocytosis, and related disorders","volume":"373","author":"Theoharides","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.iac.2016.08.017_bib2","series-title":"Anaphylaxis and hypersensitivity reactions","first-page":"257","article-title":"Anaphylaxis in mastocytosis","author":"Escribano","year":"2011"},{"issue":"23","key":"10.1016\/j.iac.2016.08.017_bib3","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"issue":"8","key":"10.1016\/j.iac.2016.08.017_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s12032-014-0123-4","article-title":"Analysis of V600E BRAF and D816V KIT mutations in systemic mastocytosis","volume":"31","author":"H\u00e4gglund","year":"2014","journal-title":"Med Oncol"},{"key":"10.1016\/j.iac.2016.08.017_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1016\/j.iac.2016.08.017_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1007\/s11882-011-0199-2","article-title":"Update on diagnosis and treatment of mastocytosis","volume":"11","author":"Brockow","year":"2011","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.iac.2016.08.017_bib7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients","volume":"124","author":"Escribano","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2016.08.017_bib8","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.jaci.2013.06.020","article-title":"Nonaggressive systemic mastocytosis (SM) without skin lesions associated with insect-induced anaphylaxis shows unique features versus other indolent SM","volume":"133","author":"Alvarez-Twose","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2016.08.017_bib9","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3324\/haematol.2010.034553","article-title":"Isolated bone marrow mastocytosis: an underestimated subvariant of indolent systemic mastocytosis","volume":"96","author":"Zanotti","year":"2011","journal-title":"Haematologica"},{"key":"10.1016\/j.iac.2016.08.017_bib10","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1182\/blood-2010-05-285270","article-title":"The classification of systemic mastocytosis should include mast cell leukemia (MCL) and systemic mastocytosis with a clonal hematologic non-mast cell lineage disease (SM-AHNMD)","volume":"116","author":"Valent","year":"2010","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.iac.2016.08.017_bib11","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.jaci.2011.01.038","article-title":"World Allergy Organization anaphylaxis guidelines: summary","volume":"127","author":"Simons","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.iac.2016.08.017_bib12","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jaci.2005.12.1303","article-title":"Second symposium on the definition and management of anaphylaxis: summary report \u2013 Second National Institute of Allergy and Infectious Disease\/Food Allergy and Anaphylaxis Network symposium","volume":"117","author":"Sampson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000096442","article-title":"Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: monoclonal mast cell activation syndrome","volume":"142","author":"Sonneck","year":"2007","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib14","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1182\/blood-2006-06-028100","article-title":"Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis","volume":"110","author":"Akin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.iac.2016.08.017_bib15","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/S0140-6736(96)07056-0","article-title":"Mastocytosis","volume":"349","author":"Golkar","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2016.08.017_bib16","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jaci.2012.10.015","article-title":"Prevalence of indolent systemic mastocytosis in a Dutch region","volume":"131","author":"van Doormaal","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.iac.2016.08.017_bib17","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/bjh.12916","article-title":"Epidemiology of systemic mastocytosis in Denmark","volume":"166","author":"Cohen","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.iac.2016.08.017_bib18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1067\/mjd.2003.98","article-title":"Assessment of the extent of cutaneous involvement in children and adults with mastocytosis: relationship to symptomatology, tryptase levels and bone marrow pathology","volume":"48","author":"Brockow","year":"2003","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.iac.2016.08.017_bib19","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1111\/j.1365-2222.2007.02804.x","article-title":"Prevalence of allergy and anaphylactic symptoms in 210 adults and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA)","volume":"37","author":"Gonz\u00e1lez-de-Olano","year":"2007","journal-title":"Clin Exp Allergy"},{"issue":"2","key":"10.1016\/j.iac.2016.08.017_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jaci.2013.08.016","article-title":"Anaphylaxis in America: the prevalence and characteristics of anaphylaxis in the United States","volume":"133","author":"Wood","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.iac.2016.08.017_bib21","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/all.12272","article-title":"The epidemiology of anaphylaxis in Europe: a systematic review","volume":"68","author":"Panesar","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2016.08.017_bib22","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1398-9995.2007.01569.x","article-title":"Anaphylaxis in patients with mastocytosis: a study on history, clinical features and risk factors in 120 patients","volume":"63","author":"Brockow","year":"2008","journal-title":"Allergy"},{"issue":"1","key":"10.1016\/j.iac.2016.08.017_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/cea.12225","article-title":"High prevalence of anaphylaxis in patients with systemic mastocytosis: a single-centre experience","volume":"44","author":"G\u00fclen","year":"2014","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.iac.2016.08.017_bib24","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/pde.12291","article-title":"Severity of cutaneous findings predict the presence of systemic symptoms in pediatric maculopapular cutaneous mastocytosis","volume":"31","author":"Barnes","year":"2014","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.iac.2016.08.017_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11882-015-0525-1","article-title":"Cutaneous and systemic mastocytosis in children: a risk factor for anaphylaxis?","volume":"15","author":"Matito","year":"2015","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.iac.2016.08.017_bib26","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/j.1398-9995.2012.02812.x","article-title":"Increased serum baseline tryptase levels and extensive skin involvement are predictors for the severity of mast cell activation episodes in children with mastocytosis","volume":"67","author":"Alvarez-Twose","year":"2012","journal-title":"Allergy"},{"issue":"10","key":"10.1016\/j.iac.2016.08.017_bib27","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1111\/all.12013","article-title":"Extensive blistering is a predictor for severe complications in children with mastocytosis","volume":"67","author":"Brockow","year":"2012","journal-title":"Allergy"},{"issue":"1\u20132","key":"10.1016\/j.iac.2016.08.017_bib28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.20452\/pamw.2644","article-title":"Risk factors for anaphylaxis in patients with mastocytosis","volume":"125","author":"G\u00f3rska","year":"2015","journal-title":"Pol Arch Med Wewn"},{"issue":"6","key":"10.1016\/j.iac.2016.08.017_bib29","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","article-title":"Clinical, biological and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms","volume":"125","author":"Alvarez-Twose","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jaci.2012.12.1578","article-title":"Higher mast cell load decreases risk of Hymenoptera venom-induced anaphylaxis in patients with mastocytosis","volume":"132","author":"van Anrooij","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"3","key":"10.1016\/j.iac.2016.08.017_bib31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaci.2013.02.019","article-title":"KIT D816V mutation burden does not correlate to clinical manifestations of indolent systemic mastocytosis","volume":"132","author":"Broesby-Olsen","year":"2013","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2016.08.017_bib32","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/BF00370723","article-title":"Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes","volume":"287","author":"Grabbe","year":"1994","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.iac.2016.08.017_bib33","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.jaci.2007.12.273","article-title":"Differences in the clinical presentation of anaphylaxis in patients with indolent systemic mastocytosis versus idiopathic anaphylaxis [abstract]","volume":"121","author":"Koterba","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"9","key":"10.1016\/j.iac.2016.08.017_bib34","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1111\/j.1398-9995.2009.02108.x","article-title":"How much specific is the association between Hymenoptera venom allergy and mastocytosis?","volume":"64","author":"Bonadonna","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2016.08.017_bib35","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0889-8588(05)70301-4","article-title":"Treatment of systemic mast cell disorders","volume":"14","author":"Worobec","year":"2000","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.iac.2016.08.017_bib36","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2008.11.018","article-title":"Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels","volume":"123","author":"Bonadonna","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0140-6736(00)03647-3","article-title":"Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings","volume":"357","author":"Ludolph-Hauser","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.iac.2016.08.017_bib38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jaci.2009.08.027","article-title":"Predictors of severe systemic anaphylactic reactions in patients with Hymenoptera venom allergy: importance of baseline serum tryptase. A study of the European Academy of Allergology and clinical immunology interest group on insect venom hypersensitivity","volume":"124","author":"Rueff","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib39","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1365-2222.2009.03210.x","article-title":"Cutaneous manifestations in Hymenoptera and Diptera anaphylaxis: relationship with basal serum tryptase","volume":"39","author":"Potier","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"5","key":"10.1016\/j.iac.2016.08.017_bib40","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1111\/all.12850","article-title":"Added sensitivity of component-resolved diagnosis in Hymenoptera venom-allergic patients with elevated serum tryptase and\/or mastocytosis","volume":"71","author":"Michel","year":"2016","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.iac.2016.08.017_bib41","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.b.20577","article-title":"Evaluation of basophil activation in mastocytosis with Hymenoptera venom anaphylaxis","volume":"80","author":"Gonz\u00e1lez-de-Olano","year":"2011","journal-title":"Cytometry B Clin Cytom"},{"issue":"3","key":"10.1016\/j.iac.2016.08.017_bib42","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jaip.2015.11.027","article-title":"Alpha-Gal: a new clue for anaphylaxis in mastocytosis","volume":"4","author":"Roenneberg","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.iac.2016.08.017_bib43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jaip.2015.01.011","article-title":"Systemic mastocytosis presenting as IgE-mediated food-induced anaphylaxis: a report of two cases","volume":"3","author":"Prieto-Garc\u00eda","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2016.08.017_bib44","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/ACI.0b013e328355b7cb","article-title":"Drug allergy in mast cell disease","volume":"12","author":"Brockow","year":"2012","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib45","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1046\/j.1365-2044.1998.00536.x","article-title":"Systemic mastocytosis presenting as profound cardiovascular collapse during anaesthesia","volume":"53","author":"Vaughan","year":"1993","journal-title":"Anaesthesia"},{"key":"10.1016\/j.iac.2016.08.017_bib46","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/S0750-7658(01)00536-6","article-title":"Circulatory arrest in the course of anaesthesia for a child with mastocytosis","volume":"20","author":"Tirel","year":"2001","journal-title":"Ann Fr Anesth Reanim"},{"issue":"1","key":"10.1016\/j.iac.2016.08.017_bib47","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000436969","article-title":"Management of anesthesia in adult and pediatric mastocytosis: a study of the Spanish network on mastocytosis (REMA) based on 726 anesthetic procedures","volume":"167","author":"Matito","year":"2015","journal-title":"Int Arch Allergy Immunol"},{"issue":"10","key":"10.1016\/j.iac.2016.08.017_bib48","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0025-6196(12)61825-4","article-title":"Increased plasma calcitonin levels in systemic mast cell disease","volume":"69","author":"Yocum","year":"1994","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"10.1016\/j.iac.2016.08.017_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1710-1492-10-19","article-title":"Non-steroidal anti-inflammatory drug hypersensitivity: association with elevated basal serum tryptase?","volume":"10","author":"Seitz","year":"2014","journal-title":"Allergy Asthma Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib50","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000328760","article-title":"Definition, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: a consensus proposal","volume":"157","author":"Valent","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib51","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1046\/j.1365-2222.2003.01755.x","article-title":"Elevated basal serum tryptase and Hymenoptera venom allergy: relation to severity of sting reactions and to safety and efficacy of venom immunotherapy","volume":"33","author":"Haeberli","year":"2003","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.08.017_bib52","first-page":"4","article-title":"Management and prevention of anaphylaxis","volume":"22","author":"Irani","year":"2015","journal-title":"F1000Res"},{"issue":"4","key":"10.1016\/j.iac.2016.08.017_bib53","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.jaci.2009.08.025","article-title":"Anaphylaxis: recent advances in assessment and treatment","volume":"124","author":"Simons","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/BF03361374","article-title":"Insektengiftallergie","volume":"13","author":"Przybilla","year":"2004","journal-title":"Allergo J"},{"issue":"2","key":"10.1016\/j.iac.2016.08.017_bib55","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/all.12548","article-title":"Effects of a structured educational intervention on knowledge and emergency management in patients at risk for anaphylaxis","volume":"70","author":"Brockow","year":"2015","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.iac.2016.08.017_bib56","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.resuscitation.2008.02.001","article-title":"Emergency treatment of anaphylactic reactions: guidelines for healthcare providers","volume":"77","author":"Soar","year":"2008","journal-title":"Resuscitation"},{"key":"10.1016\/j.iac.2016.08.017_bib57","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1398-9995.2009.02118.x","article-title":"Mastocytosis and insect venom allergy: diagnosis, safety and efficacy of venom immunotherapy","volume":"64","author":"Niedoszytko","year":"2009","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2016.08.017_bib58","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/01.all.0000235903.10548.63","article-title":"Mastocytosis and Hymenoptera venom allergy","volume":"6","author":"Rueff","year":"2006","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib59","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jaci.2007.11.010","article-title":"Safety and effectiveness of immunotherapy in patients with indolent systemic mastocytosis presenting with Hymenoptera venom anaphylaxis","volume":"121","author":"Gonzalez de Olano","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0091-6749(97)70188-X","article-title":"Hymenoptera sting anaphylaxis and urticaria pigmentosa: clinical findings and results of venom immunotherapy in ten patients","volume":"100","author":"Fricker","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib61","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1067\/mai.2001.119154","article-title":"Patients still reacting to a sting challenge while receiving Hymenoptera venom immunotherapy are protected by increased venom doses","volume":"108","author":"Rueff","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.08.017_bib62","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0091-6749(97)81058-5","article-title":"Fatal anaphylaxis after yellow jacket sting, despite venom immunotherapy, in two patients with mastocytosis","volume":"99","author":"Elberink","year":"1997","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.iac.2016.08.017_bib63","first-page":"69","article-title":"Fatal outcome of a vespula sting in a patient with mastocytosis after specific immunotherapy with honey bee venom","volume":"17","author":"Reimers","year":"2005","journal-title":"Allergy Clin Immunol Int J WAO Org"},{"issue":"2","key":"10.1016\/j.iac.2016.08.017_bib64","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1213\/ane.0b013e31817e6d7c","article-title":"Pediatric mastocytosis: routine anesthetic management for a complex disease","volume":"197","author":"Carter","year":"2008","journal-title":"Anesth Analg"},{"issue":"3","key":"10.1016\/j.iac.2016.08.017_bib65","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jaip.2014.03.009","article-title":"Omalizumab as a desensitizing agent and treatment in mastocytosis: a review of the literature and case report","volume":"2","author":"Sokol","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.iac.2016.08.017_bib66","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1159\/000329218","article-title":"Severe life-threatening or disabling anaphylaxis in patients with systemic mastocytosis: a single-center experience","volume":"157","author":"Wimazal","year":"2012","journal-title":"Int Arch Allergy Immunol"},{"issue":"26","key":"10.1016\/j.iac.2016.08.017_bib67","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1056\/NEJMoa1513098","article-title":"Efficacy and safety of midostaurin in advanced systemic mastocytosis","volume":"374","author":"Gotlib","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.iac.2016.08.017_bib68","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ejh.12544","article-title":"Current treatment options in patients with mastocytosis: status in 2015 and future perspectives","volume":"94","author":"Arock","year":"2015","journal-title":"Eur J Haematol"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T22:25:10Z","timestamp":1749680710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856116300807"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S0889856116300807"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2016.08.017","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mastocytosis and Anaphylaxis","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2016.08.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}